BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30475253)

  • 21. Argyrophil cells in the urachal epithelium and urachal adenocarcinoma.
    Satake T; Takeda A; Matsuyama M
    Acta Pathol Jpn; 1984 Sep; 34(5):1193-9. PubMed ID: 6391081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
    Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urachal carcinoma: surgical and chemotherapeutic options.
    Siefker-Radtke A
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1715-21. PubMed ID: 17181485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder.
    Behzatoğlu K
    Ann Diagn Pathol; 2011 Dec; 15(6):422-6. PubMed ID: 21855380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
    Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
    Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
    Sun W; Herrera GA
    Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma.
    Croft PR; Lathrop SL; Feddersen RM; Joste NE
    Arch Pathol Lab Med; 2005 Feb; 129(2):194-9. PubMed ID: 15679420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive, low-grade papillary urothelial carcinoma in the urachus.
    Pedersen GL; Dahl C; Azawi NH
    BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24285805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urachal remnants: benign or malignant?
    Bourne CW; May JE
    J Urol; 1977 Nov; 118(5):743-7. PubMed ID: 916092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrogenic Adenoma Intermixed With Urothelial Carcinoma.
    Kryvenko ON; Wasco MJ; Williamson SR
    Arch Pathol Lab Med; 2022 May; 147(5):552-558. PubMed ID: 35976666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IMP3 expression in urothelial carcinomas of the urinary bladder.
    Ozdemir NO; Türk NS; Düzcan E
    Turk Patoloji Derg; 2011 Jan; 27(1):31-7. PubMed ID: 21469424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.
    Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.
    McKenney JK; Gomez JA; Desai S; Lee MW; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):356-62. PubMed ID: 11224606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment methods as a prognostic factor in eight patients with urachal carcinoma].
    Yamada T; Fukui I; Sekine H; Kihara K; Oshima H
    Hinyokika Kiyo; 1991 Feb; 37(2):113-6. PubMed ID: 2048489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Urachal adenocarcinoma associated with urothelial tumor of the bladder. Report of a case].
    Payen E; Lechevallier E; Bretheau D; Lepidi H; de Fromont M; Coulange C
    Prog Urol; 1996 Apr; 6(2):288-91. PubMed ID: 8777426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urachal carcinoma: a report of two cases.
    Lin CN; Lu NM; Chiang HS; Kuo C
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Dec; 56(6):436-9. PubMed ID: 8851487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case of the month. Urachal carcinoma.
    Binkovitz LA
    Mayo Clin Proc; 1993 Apr; 68(4):393-4. PubMed ID: 8455401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.